amiloride has been researched along with Disease Exacerbation in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (35.71) | 29.6817 |
| 2010's | 6 (42.86) | 24.3611 |
| 2020's | 3 (21.43) | 2.80 |
| Authors | Studies |
|---|---|
| Barkhof, F; Bastow, R; Braisher, M; Chandran, S; Chataway, J; Connick, P; Cranswick, G; De Angelis, F; Doshi, A; Gandini Wheeler-Kingshott, CA; Giovannoni, G; Hawkins, C; John, N; MacManus, D; Ourselin, S; Parker, RA; Pavitt, SH; Plantone, D; Prados Carrasco, F; Ross, M; Sharrack, B; Stallard, N; Stutters, J; Weir, CJ | 1 |
| Barkhof, F; Chataway, J; DeAngelis, F; Doshi, A; Gandini Wheeler-Kingshott, CAM; John, NA; MacManus, D; Marshall, I; Monteverdi, A; Parker, RA; Plantone, D; Prados, F; Schneider, T; Solanky, BS; Stutters, J; Weir, CJ | 1 |
| Alshehri, M; Desale, S; Shen, W; Wilcox, C | 1 |
| Afiune Neto, A; Alves, JG; Berwanger, O; Bortolotto, LA; Brandão, AA; Castro, I; Cesarino, EJ; Chaves, H; De David, CN; de Sousa, MR; Figueiredo Neto, JA; Franco, RS; Fuchs, FD; Fuchs, SC; Gus, M; Moreira, LB; Mota Gomes, M; Nobre, F; Nóbrega, AC; Poli-de-Figueiredo, CE; Rafaelli, L; Scala, LCN; Schlatter, R; Sesin, GP; Silva, RPE; Sobral Filho, DC; Sousa, ALL; Steffens, AA; Vilela-Martin, JF; Whelton, PK | 1 |
| Chen, CJ; Fichna, J; Gu, Y; Hao, CM; Lai, LY; Li, K; Li, M; Li, YY; Lin, SY; Liu, SJ; Peng, A; Su, W; Zhang, MM | 1 |
| Bhagatwala, J; Dong, Y; Egan, BM; Harris, RA; Huang, Y; Kotak, I; Parikh, SJ; Pierce, GL; Seigler, N; Zhu, H | 1 |
| Ilatovskaya, DV; Levchenko, V; Palygin, O; Pavlov, TS; Staruschenko, A | 1 |
| Bedford, JJ; Kalita-De Croft, P; Leader, JP; Walker, RJ | 1 |
| Mall, MA | 1 |
| Ratjen, F | 1 |
| George, T; Good, DW; Watts, BA | 1 |
| Aradi, M; Bukovics, P; Dóczi, T; Janszky, J; Orsi, G; Pál, J; Perlaki, G; Schwarcz, A; Steier, R; Sulyok, E | 1 |
| Motro, M; Shemesh, J | 1 |
| Gariépy, J; Levenson, J; Moyse, D; Simon, A | 1 |
7 trial(s) available for amiloride and Disease Exacerbation
| Article | Year |
|---|---|
Efficacy of three neuroprotective drugs in secondary progressive multiple sclerosis (MS-SMART): a phase 2b, multiarm, double-blind, randomised placebo-controlled trial.
Topics: Administration, Oral; Adult; Amiloride; Brain; Disease Progression; Double-Blind Method; Female; Fluoxetine; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Multiple Sclerosis; Multiple Sclerosis, Chronic Progressive; Neuroprotective Agents; Riluzole; Treatment Outcome | 2020 |
NAA is a Marker of Disability in Secondary-Progressive MS: A Proton MR Spectroscopic Imaging Study.
Topics: Adult; Amiloride; Aspartic Acid; Biomarkers; Child, Preschool; Cohort Studies; Cross-Sectional Studies; Disability Evaluation; Disease Progression; Double-Blind Method; Female; Fluoxetine; Humans; Image Interpretation, Computer-Assisted; Male; Middle Aged; Multiple Sclerosis, Chronic Progressive; Neuroimaging; Neuroprotective Agents; Proton Magnetic Resonance Spectroscopy; Protons; Riluzole | 2020 |
The Effect of Amiloride on Proteinuria in Patients with Proteinuric Kidney Disease.
Topics: Adult; Aged; Amiloride; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Cross-Over Studies; Disease Progression; Drug Therapy, Combination; Epithelial Sodium Channel Blockers; Female; Glomerular Filtration Rate; Humans; Male; Middle Aged; Proteinuria; Renal Insufficiency, Chronic; Treatment Outcome; Triamterene | 2021 |
Effectiveness of low-dose diuretics for blood pressure reduction to optimal values in prehypertension: a randomized clinical trial.
Topics: Adult; Amiloride; Antihypertensive Agents; Blood Pressure; Chlorthalidone; Diastole; Disease Progression; Diuretics; Double-Blind Method; Female; Humans; Male; Middle Aged; Prehypertension; Systole | 2018 |
Epithelial sodium channel inhibition by amiloride on blood pressure and cardiovascular disease risk in young prehypertensives.
Topics: Adult; Amiloride; Black or African American; Blood Pressure; Brachial Artery; Cardiovascular Diseases; Disease Progression; Epithelial Sodium Channel Blockers; Female; Humans; Male; Prehypertension; Pulse Wave Analysis; Regional Blood Flow; Risk Factors; Treatment Outcome; White People | 2014 |
Calcium channel blocker nifedipine slows down progression of coronary calcification in hypertensive patients compared with diuretics.
Topics: Aged; Amiloride; Calcinosis; Calcium Channel Blockers; Cardiomyopathies; Coronary Artery Disease; Disease Progression; Diuretics; Double-Blind Method; Drug Combinations; Female; Humans; Hydrochlorothiazide; Hypertension; Longitudinal Studies; Male; Middle Aged; Nifedipine; Tomography, X-Ray Computed | 2001 |
Differential effects of nifedipine and co-amilozide on the progression of early carotid wall changes.
Topics: Aged; Aged, 80 and over; Amiloride; Antihypertensive Agents; Atenolol; Blood Pressure; Carotid Artery, Common; Carotid Stenosis; Disease Progression; Diuretics; Dose-Response Relationship, Drug; Drug Combinations; Drug Therapy, Combination; Enalapril; Female; Follow-Up Studies; France; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Nifedipine; Risk Factors; Treatment Outcome; Ultrasonography; Vasodilator Agents | 2001 |
7 other study(ies) available for amiloride and Disease Exacerbation
| Article | Year |
|---|---|
Acid loading stimulates rat glomerular mesangial cells proliferation through Na(+)-H (+) exchanger isoform 1 (NHE1)-dependent pathway.
Topics: Acidosis; Amiloride; Animals; Blotting, Western; Cell Cycle; Cell Proliferation; Disease Progression; Flow Cytometry; Fluoresceins; Hydrogen-Ion Concentration; Mesangial Cells; Rats; Renal Insufficiency, Chronic; Sodium-Hydrogen Exchanger 1; Sodium-Hydrogen Exchangers; Staining and Labeling; Tetrazolium Salts; Thiazoles | 2013 |
Impaired epithelial Na+ channel activity contributes to cystogenesis and development of autosomal recessive polycystic kidney disease in PCK rats.
Topics: Aldosterone; Amiloride; Animals; Aquaporin 2; Disease Models, Animal; Disease Progression; Epithelial Sodium Channels; Immunohistochemistry; Kidney; Patch-Clamp Techniques; Polycystic Kidney, Autosomal Recessive; Rats; Rats, Sprague-Dawley; Sodium | 2015 |
Amiloride modifies the progression of lithium-induced renal interstitial fibrosis.
Topics: Amiloride; Animals; beta Catenin; Collagen Type III; Connective Tissue Growth Factor; Cytoprotection; Diabetes Insipidus, Nephrogenic; Disease Models, Animal; Disease Progression; Epithelial Sodium Channel Blockers; Fibrosis; Glycogen Synthase Kinase 3 beta; Kidney; Kidney Diseases; Lithium Carbonate; Male; Myofibroblasts; Rats, Wistar; Transforming Growth Factor beta1 | 2018 |
Role of the amiloride-sensitive epithelial Na+ channel in the pathogenesis and as a therapeutic target for cystic fibrosis lung disease.
Topics: Amiloride; Animals; Cystic Fibrosis; Disease Models, Animal; Disease Progression; Epithelial Sodium Channel Blockers; Epithelial Sodium Channels; Lung; Mice; Mice, Inbred CFTR; Mice, Transgenic; Sodium; Sodium Channel Blockers | 2009 |
Update in cystic fibrosis 2008.
Topics: Amiloride; Animals; Bacterial Infections; Biomarkers; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Deoxycytosine Nucleotides; Disease Progression; Humans; Inflammation; Lung; Oxadiazoles; Respiratory Function Tests; Sodium Channel Blockers; Uridine | 2009 |
Lipopolysaccharide directly alters renal tubule transport through distinct TLR4-dependent pathways in basolateral and apical membranes.
Topics: Amiloride; Animals; Bicarbonates; Butadienes; Disease Progression; Endotoxemia; Escherichia coli Infections; Escherichia coli K12; Immunity, Innate; In Vitro Techniques; Kidney Tubules; Lipid A; Lipopolysaccharides; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Nitriles; Rats; Rats, Sprague-Dawley; Serum; Signal Transduction; Sirolimus; Toll-Like Receptor 4; Urinary Tract Infections | 2009 |
The influence of benzamil hydrochloride on the evolution of hyponatremic brain edema as assessed by in vivo MRI study in rats.
Topics: Amiloride; Animals; Brain Edema; Diffusion Magnetic Resonance Imaging; Disease Models, Animal; Disease Progression; Hyponatremia; Injections, Intraventricular; Male; Rats; Rats, Wistar; Sodium Channel Blockers; Sodium Channels; Treatment Outcome | 2011 |